Download antimicrobial use

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts

Pharmacokinetics wikipedia, lookup

Theralizumab wikipedia, lookup

Bilastine wikipedia, lookup

Prescription costs wikipedia, lookup

Pharmacogenomics wikipedia, lookup

Bad Pharma wikipedia, lookup

Adherence (medicine) wikipedia, lookup

Psychedelic therapy wikipedia, lookup

Vancomycin wikipedia, lookup

Dydrogesterone wikipedia, lookup

Ciprofloxacin wikipedia, lookup

Transcript
E. References
1. Ramirez JA. Antibiotic streamlining: development and justification of an antibiotic
streamlining program. Pharmacy Practice Management Quarterly 1996;16:19-34.
2. Cunha BA. Community-acquired pneumonia-cost-effective antimicrobial therapy. Postgrad
Med 1996;99:62-4.
3. Okapara AU, Maswoswe JJ, Stewart K. Criteria-based antimicrobial i.v. to oral conversion
program. Formulary 1995;30:343-8.
4. Jewesson P. Cost-effectiveness and value of an IV switch. Pharmacoeconomics 1994;
5(Suppl 2):20-26.
5. Parker SE, Davey PG. Pharmacoecomics of intravenous drug administration.
Pharmacoeconomics 1992;1:103-15.
6. Przybylski KG, Rybak MJ, Martin PR, et al. A pharmacist-initiated program of intravenous to
oral antibiotic conversion. Pharmacotherapy 1997;17:271-6.
7. Zamin MT, Pitre MM, Conly JM. Development of an intravenous-to-oral conversion program
for antimicrobial therapy at a Canadian tertiary care health facility. Annals of
Pharmacotherapy 1997;31:564-70.
8. Goldwater SH, Neal-Janifer A, Milkovich G, et al. Smoothing the path for I.v.-to-oral
conversion. AJHP 1997;54:200.
9. Wetzstein GA. Intravenous to oral (iv:po) anti-infective conversion therapy. Cancer Control.
2000 Mar-Apr;7(2):170-6.
10. Fischer MA, Solomon DH, Teich JM, Avorn J. Conversion from intravenous to oral
medications: assessment of a computerized intervention for hospitalized patients. Arch Intern
Med. 2003 Nov 24;163(21):2585-9.
11. Ho BP, Lau TT, Balen RM, Naumann TL, Jewesson PJ. The impact of a pharmacistmanaged dosage form conversion service on ciprofloxacin usage at a major Canadian
teaching hospital: a pre- and post-intervention study. BMC Health Serv Res. 2005 Jun
29;5:48.
12. Teich JM, Petronzio AM, Gerner JR, Seger DL, Shek C, Fanikos J. An information system to
promote intravenous-to-oral medication conversion. Proc AMIA Symp. 1999;:415-9.
13. Pisegna JR: Switching between intravenous and oral pantoprazole. J Clin Gastroenterol
2001; 32(1):27-32.
14. Fish LH, Schwartz HL, Cavanaugh J, et al: Replacement dose, metabolism, and
bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in
pituitary feedback in humans. N Engl J Med 1987; 316(13):764-770